93. 原発性胆汁性胆管炎 Primary biliary cholangitis Clinical trials / Disease details

臨床試験数 : 298 / 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04620733 (ClinicalTrials.gov)	April 21, 2021	4/11/2020	RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequat ...	RESPONSE: A Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of Sel ...	Primary Biliary Cholangitis	Drug: Seladelpar 10 mg;Drug: Placebo;Drug: Seladelpar 5 mg	CymaBay Therapeutics, Inc.	NULL	Active, not recruiting	18 Years	75 Years	All	193	Phase 3	United States;Argentina;Australia;Austria;Belgium;Canada;Chile;Czechia;Denmark;France;Germany;Greece ...
2	NCT03301506 (ClinicalTrials.gov)	December 12, 2017	26/9/2017	Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)	ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subje ...	Primary Biliary Cirrhosis	Drug: Seladelpar 5 mg Capsule;Drug: Seladelpar 10 mg Capsule	CymaBay Therapeutics, Inc.	NULL	Recruiting	18 Years	75 Years	All	500	Phase 3	United States;Argentina;Australia;Belgium;Canada;Chile;Czechia;France;Germany;Greece;Hungary;Israel; ...

First Previous1Next Last